stock.name

Compugen Ltd

CGEN

Market Cap$238.26M
Close$

Compare Compugen Ltd

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Compugen LtdCompugen Ltd-7.10%-37%--
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$2.76

Current Fair Value

8.8% upside

Undervalued by 8.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$238.26 Million
Enterprise Value$141.34 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.39
Beta2.06
Outstanding Shares89,237,465
Avg 30 Day Volume802,839

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-7.08
PEG190.47
Price to Sales-
Price to Book Ratio2.54
Enterprise Value to Revenue23.56
Enterprise Value to EBIT-4.07
Enterprise Value to Net Income-5
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Compugen Ltd

CEO: Anat Cohen-Dayag

Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immu...